MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 10 - per page
Order by
A method of transfecting isolated autologous T-Lymphocytes with endogenous cytokines, for example IL-7 and IL-15, to sustain an adoptive T-lymphocyte response without systemic toxicity. More
Peptides and antigen epitopes specific for RCC for use in the diagnosis, vaccination, or adoptive infusion of antigen specific T cells to treat patients with metastatic RCC More
Uses of a p53 specific microRNA (miRNA): It has been reported that the tumor suppressive mRNA miR-34a (a downstream target of p53) is downregulated in HPV-infected primary keratinocytes. More
An alternative type of immunotherapy which involves the adoptive transfer of autologous natural killer (NK) cells More
Methods and formulations for treating or preventing Vascular Cognitive Impairment (VCI) through mucosal administration of E-selectin, an inducible adhesion molecule on endothelial cells More
Methods of producing a population of purified non-alloreactive antigen-specific T cells that recognize an antigen of interest More
The present invention involves the construction of hybrid anti-cancer TCR that is half mouse and half human. More
A synthetic peptide immunomodulator designed to treat Systemic Lupus Erythematosus (SLE). SLE is a chronic, disabling and potentially life-threatening autoimmune disorder that involves multiple organ systems including the skin, joints, heart, lungs,... More
Novel peptide sequences identified from breast, prostate, and bladder cancers are utilized as targets for anti-tumor vaccines. Local therapy such as surgical exicision or ablation by radiation is a mainstay for the treatment of primary cancer and is... More
Rheumatoid Arthritis patient need to undergo treatment which in many cases is not efficient and accompanied by various side effects. WIS reaearchers showed that Rheumatoid Arthritis may be treated by short peptides derived from Heat Shock Protein 60... More
Displaying 1..10 of 10 - per page
Order by

Your selection

Therapeutic target
Immune related disorders del
Adoptive immunotherapy del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us